Keklik Karadag, F. Et Al. 2021. Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis. AMERICAN JOURNAL OF BLOOD RESEARCH , vol.11, no.3 , 279-285.

Keklik Karadag, F., Yenerel, M. N., Yılmaz, M., Uskudar, H., Özkocaman, V., Fıratlı Tuglular, T., ... Erdem, F.(2021). Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis. AMERICAN JOURNAL OF BLOOD RESEARCH , vol.11, no.3, 279-285.

Keklik Karadag, Fatma Et Al. "Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis," AMERICAN JOURNAL OF BLOOD RESEARCH , vol.11, no.3, 279-285, 2021

Keklik Karadag, Fatma K. Et Al. "Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis." AMERICAN JOURNAL OF BLOOD RESEARCH , vol.11, no.3, pp.279-285, 2021

Keklik Karadag, F. Et Al. (2021) . "Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis." AMERICAN JOURNAL OF BLOOD RESEARCH , vol.11, no.3, pp.279-285.

@article{article, author={Fatma Keklik Karadag Et Al. }, title={Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis}, journal={AMERICAN JOURNAL OF BLOOD RESEARCH}, year=2021, pages={279-285} }